Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases
International Journal of Dermatology · 2023
DOI: 10.1111/ijd.16698 ↗At a glance
Fallbericht in International Journal of Dermatology, 2023. Written by Juan Bai and 3 co-authors. Institution: Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Major MEDLINE topics: Skin Diseases, Amyloidosis, Lichenoid Eruptions. Cited 15 times so far (Crossref); 5 references. Funded by: Health Science and Technology Project of Health Commission of Zhejiang Province.
Abstract (original language)
References 1 Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609–11. 2 Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250–7. 3 Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272–85. 4 Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071–80. 5 Wongkitisophon P, Chanprapaph K, Rattanakaemakorn P, Vachiramon V. Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms. Acta Derm Venereol. 2012;92:200–5.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID profiles: Jianjun Qiao
Funding
- Health Science and Technology Project of Health Commission of Zhejiang Province
Cite
APA
Bai, J., Su, W., Fang, H., & Qiao, J. (2023). Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases. International Journal of Dermatology. https://doi.org/10.1111/ijd.16698
Vancouver
Bai J, Su W, Fang H, Qiao J. Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases. International Journal of Dermatology. 2023. doi:10.1111/ijd.16698
BibTeX
@article{Bai2023,
author = {Bai, Juan and Su, Wang and Fang, Hong and Qiao, Jianjun},
title = {Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases},
journal = {International Journal of Dermatology},
year = {2023},
doi = {10.1111/ijd.16698}
}
EUVIMED